img

Global Biological Drug CDMO Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Biological Drug CDMO Market Insights, Forecast to 2034

Biological drug CDMO (Contract Development and Manufacturing Organization) is a company that specializes in the development and manufacturing of biological drugs. Biological drugs are complex molecules that are produced from living cells, and they include a wide range of products such as vaccines, monoclonal antibodies, and cell therapies.
Market Analysis and InsightsGlobal Biological Drug CDMO Market
Global Biological Drug CDMO market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Biological Drug CDMO industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Biological Drug CDMO market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Biological Drug CDMO market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Samsung Biologics
Lonza
Boehringer Ingelheim
Catalent
BioCentriq
FUJIFILM Diosynth Biotechnologies
Thermo Fisher Scientific
Recipharm
Delpharm
Aenova
Siegfried
WuXi Biologics
Obio Technology
Hepalink
Pharmaron
ChemPartner
Segment by Type
Innovative Drug
Listed Patent Drugs
Biosimilar

Segment by Application


Pharmaceutical Company
Biotechnology Company
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Biological Drug CDMO introduction, etc. Biological Drug CDMO Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Biological Drug CDMO
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biological Drug CDMO Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Innovative Drug
1.2.3 Listed Patent Drugs
1.2.4 Biosimilar
1.3 Market by Application
1.3.1 Global Biological Drug CDMO Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biological Drug CDMO Market Perspective (2018-2033)
2.2 Global Biological Drug CDMO Growth Trends by Region
2.2.1 Biological Drug CDMO Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Biological Drug CDMO Historic Market Size by Region (2018-2023)
2.2.3 Biological Drug CDMO Forecasted Market Size by Region (2024-2033)
2.3 Biological Drug CDMO Market Dynamics
2.3.1 Biological Drug CDMO Industry Trends
2.3.2 Biological Drug CDMO Market Drivers
2.3.3 Biological Drug CDMO Market Challenges
2.3.4 Biological Drug CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Biological Drug CDMO by Players
3.1.1 Global Biological Drug CDMO Revenue by Players (2018-2023)
3.1.2 Global Biological Drug CDMO Revenue Market Share by Players (2018-2023)
3.2 Global Biological Drug CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Biological Drug CDMO, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Biological Drug CDMO Market Concentration Ratio
3.4.1 Global Biological Drug CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biological Drug CDMO Revenue in 2022
3.5 Global Key Players of Biological Drug CDMO Head office and Area Served
3.6 Global Key Players of Biological Drug CDMO, Product and Application
3.7 Global Key Players of Biological Drug CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biological Drug CDMO Breakdown Data by Type
4.1 Global Biological Drug CDMO Historic Market Size by Type (2018-2023)
4.2 Global Biological Drug CDMO Forecasted Market Size by Type (2024-2033)
5 Biological Drug CDMO Breakdown Data by Application
5.1 Global Biological Drug CDMO Historic Market Size by Application (2018-2023)
5.2 Global Biological Drug CDMO Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Biological Drug CDMO Market Size (2018-2033)
6.2 North America Biological Drug CDMO Market Size by Type
6.2.1 North America Biological Drug CDMO Market Size by Type (2018-2023)
6.2.2 North America Biological Drug CDMO Market Size by Type (2024-2033)
6.2.3 North America Biological Drug CDMO Market Share by Type (2018-2033)
6.3 North America Biological Drug CDMO Market Size by Application
6.3.1 North America Biological Drug CDMO Market Size by Application (2018-2023)
6.3.2 North America Biological Drug CDMO Market Size by Application (2024-2033)
6.3.3 North America Biological Drug CDMO Market Share by Application (2018-2033)
6.4 North America Biological Drug CDMO Market Size by Country
6.4.1 North America Biological Drug CDMO Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Biological Drug CDMO Market Size by Country (2018-2023)
6.4.3 North America Biological Drug CDMO Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Biological Drug CDMO Market Size (2018-2033)
7.2 Europe Biological Drug CDMO Market Size by Type
7.2.1 Europe Biological Drug CDMO Market Size by Type (2018-2023)
7.2.2 Europe Biological Drug CDMO Market Size by Type (2024-2033)
7.2.3 Europe Biological Drug CDMO Market Share by Type (2018-2033)
7.3 Europe Biological Drug CDMO Market Size by Application
7.3.1 Europe Biological Drug CDMO Market Size by Application (2018-2023)
7.3.2 Europe Biological Drug CDMO Market Size by Application (2024-2033)
7.3.3 Europe Biological Drug CDMO Market Share by Application (2018-2033)
7.4 Europe Biological Drug CDMO Market Size by Country
7.4.1 Europe Biological Drug CDMO Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Biological Drug CDMO Market Size by Country (2018-2023)
7.4.3 Europe Biological Drug CDMO Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Biological Drug CDMO Market Size (2018-2033)
8.2 China Biological Drug CDMO Market Size by Type
8.2.1 China Biological Drug CDMO Market Size by Type (2018-2023)
8.2.2 China Biological Drug CDMO Market Size by Type (2024-2033)
8.2.3 China Biological Drug CDMO Market Share by Type (2018-2033)
8.3 China Biological Drug CDMO Market Size by Application
8.3.1 China Biological Drug CDMO Market Size by Application (2018-2023)
8.3.2 China Biological Drug CDMO Market Size by Application (2024-2033)
8.3.3 China Biological Drug CDMO Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Biological Drug CDMO Market Size (2018-2033)
9.2 Asia Biological Drug CDMO Market Size by Type
9.2.1 Asia Biological Drug CDMO Market Size by Type (2018-2023)
9.2.2 Asia Biological Drug CDMO Market Size by Type (2024-2033)
9.2.3 Asia Biological Drug CDMO Market Share by Type (2018-2033)
9.3 Asia Biological Drug CDMO Market Size by Application
9.3.1 Asia Biological Drug CDMO Market Size by Application (2018-2023)
9.3.2 Asia Biological Drug CDMO Market Size by Application (2024-2033)
9.3.3 Asia Biological Drug CDMO Market Share by Application (2018-2033)
9.4 Asia Biological Drug CDMO Market Size by Region
9.4.1 Asia Biological Drug CDMO Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Biological Drug CDMO Market Size by Region (2018-2023)
9.4.3 Asia Biological Drug CDMO Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Biological Drug CDMO Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Biological Drug CDMO Market Size by Type
10.2.1 Middle East, Africa, and Latin America Biological Drug CDMO Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Biological Drug CDMO Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Biological Drug CDMO Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Biological Drug CDMO Market Size by Application
10.3.1 Middle East, Africa, and Latin America Biological Drug CDMO Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Biological Drug CDMO Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Biological Drug CDMO Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Biological Drug CDMO Market Size by Country
10.4.1 Middle East, Africa, and Latin America Biological Drug CDMO Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Biological Drug CDMO Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Biological Drug CDMO Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Samsung Biologics
11.1.1 Samsung Biologics Company Details
11.1.2 Samsung Biologics Business Overview
11.1.3 Samsung Biologics Biological Drug CDMO Introduction
11.1.4 Samsung Biologics Revenue in Biological Drug CDMO Business (2018-2023)
11.1.5 Samsung Biologics Recent Developments
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Biological Drug CDMO Introduction
11.2.4 Lonza Revenue in Biological Drug CDMO Business (2018-2023)
11.2.5 Lonza Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Biological Drug CDMO Introduction
11.3.4 Boehringer Ingelheim Revenue in Biological Drug CDMO Business (2018-2023)
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Catalent
11.4.1 Catalent Company Details
11.4.2 Catalent Business Overview
11.4.3 Catalent Biological Drug CDMO Introduction
11.4.4 Catalent Revenue in Biological Drug CDMO Business (2018-2023)
11.4.5 Catalent Recent Developments
11.5 BioCentriq
11.5.1 BioCentriq Company Details
11.5.2 BioCentriq Business Overview
11.5.3 BioCentriq Biological Drug CDMO Introduction
11.5.4 BioCentriq Revenue in Biological Drug CDMO Business (2018-2023)
11.5.5 BioCentriq Recent Developments
11.6 FUJIFILM Diosynth Biotechnologies
11.6.1 FUJIFILM Diosynth Biotechnologies Company Details
11.6.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.6.3 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Introduction
11.6.4 FUJIFILM Diosynth Biotechnologies Revenue in Biological Drug CDMO Business (2018-2023)
11.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Details
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Biological Drug CDMO Introduction
11.7.4 Thermo Fisher Scientific Revenue in Biological Drug CDMO Business (2018-2023)
11.7.5 Thermo Fisher Scientific Recent Developments
11.8 Recipharm
11.8.1 Recipharm Company Details
11.8.2 Recipharm Business Overview
11.8.3 Recipharm Biological Drug CDMO Introduction
11.8.4 Recipharm Revenue in Biological Drug CDMO Business (2018-2023)
11.8.5 Recipharm Recent Developments
11.9 Delpharm
11.9.1 Delpharm Company Details
11.9.2 Delpharm Business Overview
11.9.3 Delpharm Biological Drug CDMO Introduction
11.9.4 Delpharm Revenue in Biological Drug CDMO Business (2018-2023)
11.9.5 Delpharm Recent Developments
11.10 Aenova
11.10.1 Aenova Company Details
11.10.2 Aenova Business Overview
11.10.3 Aenova Biological Drug CDMO Introduction
11.10.4 Aenova Revenue in Biological Drug CDMO Business (2018-2023)
11.10.5 Aenova Recent Developments
11.11 Siegfried
11.11.1 Siegfried Company Details
11.11.2 Siegfried Business Overview
11.11.3 Siegfried Biological Drug CDMO Introduction
11.11.4 Siegfried Revenue in Biological Drug CDMO Business (2018-2023)
11.11.5 Siegfried Recent Developments
11.12 WuXi Biologics
11.12.1 WuXi Biologics Company Details
11.12.2 WuXi Biologics Business Overview
11.12.3 WuXi Biologics Biological Drug CDMO Introduction
11.12.4 WuXi Biologics Revenue in Biological Drug CDMO Business (2018-2023)
11.12.5 WuXi Biologics Recent Developments
11.13 Obio Technology
11.13.1 Obio Technology Company Details
11.13.2 Obio Technology Business Overview
11.13.3 Obio Technology Biological Drug CDMO Introduction
11.13.4 Obio Technology Revenue in Biological Drug CDMO Business (2018-2023)
11.13.5 Obio Technology Recent Developments
11.14 Hepalink
11.14.1 Hepalink Company Details
11.14.2 Hepalink Business Overview
11.14.3 Hepalink Biological Drug CDMO Introduction
11.14.4 Hepalink Revenue in Biological Drug CDMO Business (2018-2023)
11.14.5 Hepalink Recent Developments
11.15 Pharmaron
11.15.1 Pharmaron Company Details
11.15.2 Pharmaron Business Overview
11.15.3 Pharmaron Biological Drug CDMO Introduction
11.15.4 Pharmaron Revenue in Biological Drug CDMO Business (2018-2023)
11.15.5 Pharmaron Recent Developments
11.16 ChemPartner
11.16.1 ChemPartner Company Details
11.16.2 ChemPartner Business Overview
11.16.3 ChemPartner Biological Drug CDMO Introduction
11.16.4 ChemPartner Revenue in Biological Drug CDMO Business (2018-2023)
11.16.5 ChemPartner Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biological Drug CDMO Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Innovative Drug
Table 3. Key Players of Listed Patent Drugs
Table 4. Key Players of Biosimilar
Table 5. Global Biological Drug CDMO Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Biological Drug CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Biological Drug CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Biological Drug CDMO Market Share by Region (2018-2023)
Table 9. Global Biological Drug CDMO Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Biological Drug CDMO Market Share by Region (2024-2033)
Table 11. Biological Drug CDMO Market Trends
Table 12. Biological Drug CDMO Market Drivers
Table 13. Biological Drug CDMO Market Challenges
Table 14. Biological Drug CDMO Market Restraints
Table 15. Global Biological Drug CDMO Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Biological Drug CDMO Revenue Share by Players (2018-2023)
Table 17. Global Top Biological Drug CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Drug CDMO as of 2022)
Table 18. Global Biological Drug CDMO Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Biological Drug CDMO Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Biological Drug CDMO, Headquarters and Area Served
Table 21. Global Key Players of Biological Drug CDMO, Product and Application
Table 22. Global Key Players of Biological Drug CDMO, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biological Drug CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Biological Drug CDMO Revenue Market Share by Type (2018-2023)
Table 26. Global Biological Drug CDMO Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Biological Drug CDMO Revenue Market Share by Type (2024-2033)
Table 28. Global Biological Drug CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Biological Drug CDMO Revenue Share by Application (2018-2023)
Table 30. Global Biological Drug CDMO Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Biological Drug CDMO Revenue Share by Application (2024-2033)
Table 32. North America Biological Drug CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Biological Drug CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Biological Drug CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Biological Drug CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Biological Drug CDMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Biological Drug CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Biological Drug CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Biological Drug CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Biological Drug CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Biological Drug CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Biological Drug CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Biological Drug CDMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Biological Drug CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Biological Drug CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Biological Drug CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Biological Drug CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Biological Drug CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Biological Drug CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Biological Drug CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Biological Drug CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Biological Drug CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Biological Drug CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Biological Drug CDMO Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Biological Drug CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Biological Drug CDMO Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Biological Drug CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Biological Drug CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Biological Drug CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Biological Drug CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Biological Drug CDMO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Biological Drug CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Biological Drug CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 64. Samsung Biologics Company Details
Table 65. Samsung Biologics Business Overview
Table 66. Samsung Biologics Biological Drug CDMO Product
Table 67. Samsung Biologics Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 68. Samsung Biologics Recent Developments
Table 69. Lonza Company Details
Table 70. Lonza Business Overview
Table 71. Lonza Biological Drug CDMO Product
Table 72. Lonza Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 73. Lonza Recent Developments
Table 74. Boehringer Ingelheim Company Details
Table 75. Boehringer Ingelheim Business Overview
Table 76. Boehringer Ingelheim Biological Drug CDMO Product
Table 77. Boehringer Ingelheim Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 78. Boehringer Ingelheim Recent Developments
Table 79. Catalent Company Details
Table 80. Catalent Business Overview
Table 81. Catalent Biological Drug CDMO Product
Table 82. Catalent Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 83. Catalent Recent Developments
Table 84. BioCentriq Company Details
Table 85. BioCentriq Business Overview
Table 86. BioCentriq Biological Drug CDMO Product
Table 87. BioCentriq Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 88. BioCentriq Recent Developments
Table 89. FUJIFILM Diosynth Biotechnologies Company Details
Table 90. FUJIFILM Diosynth Biotechnologies Business Overview
Table 91. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Product
Table 92. FUJIFILM Diosynth Biotechnologies Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 93. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 94. Thermo Fisher Scientific Company Details
Table 95. Thermo Fisher Scientific Business Overview
Table 96. Thermo Fisher Scientific Biological Drug CDMO Product
Table 97. Thermo Fisher Scientific Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 98. Thermo Fisher Scientific Recent Developments
Table 99. Recipharm Company Details
Table 100. Recipharm Business Overview
Table 101. Recipharm Biological Drug CDMO Product
Table 102. Recipharm Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 103. Recipharm Recent Developments
Table 104. Delpharm Company Details
Table 105. Delpharm Business Overview
Table 106. Delpharm Biological Drug CDMO Product
Table 107. Delpharm Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 108. Delpharm Recent Developments
Table 109. Aenova Company Details
Table 110. Aenova Business Overview
Table 111. Aenova Biological Drug CDMO Product
Table 112. Aenova Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 113. Aenova Recent Developments
Table 114. Siegfried Company Details
Table 115. Siegfried Business Overview
Table 116. Siegfried Biological Drug CDMO Product
Table 117. Siegfried Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 118. Siegfried Recent Developments
Table 119. WuXi Biologics Company Details
Table 120. WuXi Biologics Business Overview
Table 121. WuXi Biologics Biological Drug CDMO Product
Table 122. WuXi Biologics Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 123. WuXi Biologics Recent Developments
Table 124. Obio Technology Company Details
Table 125. Obio Technology Business Overview
Table 126. Obio Technology Biological Drug CDMO Product
Table 127. Obio Technology Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 128. Obio Technology Recent Developments
Table 129. Hepalink Company Details
Table 130. Hepalink Business Overview
Table 131. Hepalink Biological Drug CDMO Product
Table 132. Hepalink Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 133. Hepalink Recent Developments
Table 134. Pharmaron Company Details
Table 135. Pharmaron Business Overview
Table 136. Pharmaron Biological Drug CDMO Product
Table 137. Pharmaron Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 138. Pharmaron Recent Developments
Table 139. ChemPartner Company Details
Table 140. ChemPartner Business Overview
Table 141. ChemPartner Biological Drug CDMO Product
Table 142. ChemPartner Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 143. ChemPartner Recent Developments
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biological Drug CDMO Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Biological Drug CDMO Market Share by Type: 2022 VS 2033
Figure 3. Innovative Drug Features
Figure 4. Listed Patent Drugs Features
Figure 5. Biosimilar Features
Figure 6. Global Biological Drug CDMO Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Biological Drug CDMO Market Share by Application: 2022 VS 2033
Figure 8. Pharmaceutical Company Case Studies
Figure 9. Biotechnology Company Case Studies
Figure 10. Biological Drug CDMO Report Years Considered
Figure 11. Global Biological Drug CDMO Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Biological Drug CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Biological Drug CDMO Market Share by Region: 2022 VS 2033
Figure 14. Global Biological Drug CDMO Market Share by Players in 2022
Figure 15. Global Top Biological Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Drug CDMO as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Biological Drug CDMO Revenue in 2022
Figure 17. North America Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Biological Drug CDMO Market Share by Type (2018-2033)
Figure 19. North America Biological Drug CDMO Market Share by Application (2018-2033)
Figure 20. North America Biological Drug CDMO Market Share by Country (2018-2033)
Figure 21. United States Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Biological Drug CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Biological Drug CDMO Market Share by Type (2018-2033)
Figure 25. Europe Biological Drug CDMO Market Share by Application (2018-2033)
Figure 26. Europe Biological Drug CDMO Market Share by Country (2018-2033)
Figure 27. Germany Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Biological Drug CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Biological Drug CDMO Market Share by Type (2018-2033)
Figure 35. China Biological Drug CDMO Market Share by Application (2018-2033)
Figure 36. Asia Biological Drug CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Biological Drug CDMO Market Share by Type (2018-2033)
Figure 38. Asia Biological Drug CDMO Market Share by Application (2018-2033)
Figure 39. Asia Biological Drug CDMO Market Share by Region (2018-2033)
Figure 40. Japan Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Biological Drug CDMO Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Biological Drug CDMO Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Biological Drug CDMO Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Biological Drug CDMO Market Share by Country (2018-2033)
Figure 50. Brazil Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Samsung Biologics Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 57. Lonza Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 58. Boehringer Ingelheim Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 59. Catalent Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 60. BioCentriq Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 61. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 63. Recipharm Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 64. Delpharm Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 65. Aenova Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 66. Siegfried Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 67. WuXi Biologics Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 68. Obio Technology Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 69. Hepalink Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 70. Pharmaron Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 71. ChemPartner Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries